Skip to main content
|
Go home
Go home

Renown Expands Cancer Care Leadership with New Section Chief of Oncology

Renown Health logo

Dr. Harry Menon Named Oncology Section Chief

Renown Health is delighted to announce the promotion of Dr. Harry Menon to Section Chief of Oncology for the William N. Pennington Cancer Institute at Renown Health, effective immediately. Dr. Menon has been a dedicated Hematology/Oncology Physician since August 2021 and has also been serving as an Assistant Professor of Clinical Internal Medicine at the University of Nevada, Reno School of Medicine. In this leadership role, Dr. Menon will oversee clinical programs, advance cancer research and innovation, and guide a multi-disciplinary team dedicated to providing exceptional care for patients and families across northern Nevada.

Dr. Menon brings a wealth of experience and expertise to his new role. He completed his fellowship in Hematology & Oncology at Pennsylvania State University Milton S. Hershey Medical Center, where he also served as Chief Fellow. Prior to that he completed a residency in Internal Medicine at Inspira Health Network in New Jersey, where he also served as Chief Resident. His academic study includes a D.O. from Lake Erie College of Osteopathic Medicine, an M.P.H. from Boston University with a concentration in Epidemiology, Health Policy & Management, and a B.S. from Pennsylvania State University in Biochemistry and Molecular Biology.

Dr. Menon has made significant contributions to the field through his research and publications. He has authored multiple peer-reviewed articles on topics including cancer therapy, COVID-19 impact on patients with cancer, and biomarkers in cancer. His research interests include ctDNA assays, electronic patient-reported outcomes development and public health projects addressing cancer in unhoused populations. His work has been published in prestigious journals such as JAMA Network Open and Annals of Oncology. He has also presented at numerous conferences, including the ASCO Annual Meeting and the American Society of Hematology Annual Meeting. Dr. Menon is board-certified in Hematology, Medical Oncology and Internal Medicine.

Expanding Cancer Care and Research in Nevada

As Section Chief, Dr. Menon will collaborate with colleagues across Renown Heath and the University of Nevada, Reno School of Medicine to expand access to advanced cancer therapies, clinical trials, and supportive care service, ensuring that patients receive the highest-quality care close to home.

Dr. Menon’s office is located within Renown Hematology/Oncology at 75 Pringle Way, Ste 801 in Reno, NV. People interested in scheduling an appointment with Dr. Menon can call Renown’s oncology scheduling line at 775-982-4000.


About Renown Health

Renown Health is the region’s largest, locally governed, not-for-profit integrated academic health care network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 8,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Related News

Renown Health logo

Renown’s Steven Remirez Named to Becker’s ‘CISOs to Know’ List

Renown Health is proud to announce that Chief Information Officer (CISO) Steven Ramirez has been recognized by Becker’s Hospital Review as one of the nation’s “CISOs to Know.” The annual list highlights top leaders who are driving innovation, safeguarding patient information, and shaping the future of cybersecurity in healthcare.
Read More Renown’s Steven Remirez Named to Becker’s ‘CISOs to Know’ List
View All Press Releases
ER Wait Times

How are wait times calculated?

Our estimated ER wait times reflect the average time from check-in to being seen by a medical professional during triage, where patients are prioritized based on the severity of their condition.